← Explorer/Network

CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis

Fletcher J, Lonergan R, Costelloe L +5 more2009The Journal of ImmunologyJournal Article
10.4049/jimmunol.0901881PubMedFree full text
Immune/InnateNeurological

Abstract

CD39Foxp3 Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1 Jean M. Fletcher,* Roisin Lonergan,† Lisa Costelloe,† Katie Kinsella,† Barry Moran,* Cliona O’Farrelly,* Niall Tubridy,† and Kingston H. G. Mills2* Despite the fact that CD4CD25Foxp3 regulatory T cells (Treg cells) play a central role in maintaining self-tolerance and that IL-17-producing CD4 T cells (Th17 cells) are pathogenic in many autoimmune diseases, evidence to date has indicated that Th17 cells are resistant to suppression by human Foxp3 Treg cells. It was recently demonstrated that CD39, an ectonucleotidase which hydrolyzes ATP, is expressed on a subset of human natural Treg cells. We found that although both CD4CD25highCD39 and CD4CD25highCD39 T cells suppressed proliferation and IFN- production by responder T cells, only the CD4CD25high CD39, which were predominantly FoxP3, suppressed IL-17 production, whereas CD4CD25highCD39 T cells produced IL-17. An examination of T cells from multiple sclerosis patients revealed a normal frequency of CD4CD25CD127lowFoxP3, but interestingly a deficit in the relative frequency and the suppressive function of CD4CD25CD127lowFoxP3CD39 Treg cells. The mechanism of suppression by CD39 Treg cells appears to require cell contact and can be duplicated by adenosine, which is produced from ATP by the ectonucleotidases CD39 and CD73. Our findings suggest that CD4CD25Foxp3CD39 Treg cells play an important role in constraining pathogenic Th17 cells and their reduction in multiple sclerosis patients might lead to an inability to control IL-17 mediated autoimmune inflammation. The Journal of Immunology, 2009, 183: 7602–7610. I n healthy individuals naturally occurring Treg (nTreg)3 cells play an essential role in maintaining tolerance to self Ags and preventing autoimmune diseases. Multiple sclerosis (MS) is an autoimmune disease caused by pathogenic T cells specific for myelin- Ags in the CNS. T cell responses

Key Biomarkers

AdenosineCD39+Foxp3+ regulatory T cellsCD4+CD25+CD127low Treg cellsCD73IL-17-producing Th17 cells

Symptom Clusters

Autoimmune inflammationImpaired regulatory T cell suppressionPathogenic Th17 cell activity

Cited By (6)

  • An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signallingNature Communications · 2014
  • T cells in multiple sclerosis and experimental autoimmune encephalomyelitisClinical & Experimental Immunology · 2010
  • Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory PhenotypeAmerican Journal of Transplantation · 2010
  • Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory MechanismJournal of Clinical Immunology · 2011
  • Immune mechanisms of granuloma formation in sarcoidosis and tuberculosisJournal of Clinical Investigation · 2024
  • Making sense of regulatory T cell suppressive functionSeminars in Immunology · 2011

References (4)

Related Papers

  • CGRP sensory neurons promote tissue healing via neutrophils and macrophagesNature · 2024 · 2 shared tags
  • Invited review: Mechanisms of hypophagia during diseaseJournal of Dairy Science · 2021 · 2 shared tags
  • Diabetic complications and prospective immunotherapyFrontiers in Immunology · 2023 · 2 shared tags
  • Gut-Brain Inflammation Due to Toxin-Activated Mast Cells and Microglia in Autism Spectrum DisorderPreprints.org · 2025 · 2 shared tags
  • The Role of Adipokines and Myokines in the Pathogenesis of Different Obesity Phenotypes—New PerspectivesAntioxidants · 2023 · 2 shared tags
  • Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2025 · 2 shared tags
Compromised CD4+ CD25high regulatory T‐cell function in patients with relapsing‐remitting multiple sclerosis is correlated with a reduced frequency of FOXP3‐positive cells and reduced FOXP3 expression at the single‐cell level
Immunology · 2008
  • Regulatory T cells fail to suppress CD4+ T‐bet+ T cells in relapsing multiple sclerosis patientsImmunology · 2009
  • Secondary progressive in contrast to relapsing‐remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T‐cell function and FOXP3 expressionJournal of Neuroscience Research · 2006
  • Two functional subsets of FOXP3+ regulatory T cells in human thymus and peripheryImmunity · 2008